Fairvalue-Calculator Fairvalue-Calculator

Aevis Victoria SA (AEVS) Fair Value & Analysis

Healthcare · CH · Market cap CHF 1.1B

PriceCHF 12.70
Fair ValueCHF 4.05
Upside-68.1%
Quality92/100
Evidence: Medium Range CHF 3.02 – CHF 6.04

Analysis

Aevis Victoria SA (AEVS) currently trades at CHF 12.70, while our model-based Fair Value estimate is CHF 4.05 — implying the stock looks roughly 68.1% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Aevis Victoria SA engages in the healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. It operates through Hospitals, Hospitality, and Real Estate segments. The company operates private hospitals, hotels, radiology institutes, pharmacy, urology center, health center, day clinics, spas, patient hotels, and golf courses. It also provides health management programs, lifestyle coaching and anti-aging cosmeceuticals under the Nescens brand. In addition, the company offers ambulance, life sciences related services, medical home, physiotherapy, ophthalmology, sports medicine, medical radiation, stem cells, cosmetics, parking, cleaning services, sterilization, and IT related services. Further, it owns real estate properties in the healthcare and hospitality sectors. The company was founded in 2006 and is headquartered in Fribourg, Switzerland. Aevis Victoria SA operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.